+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

CRISPR Gene Editing Market by Type (Base Editing, Cas9, Cpf1), Application (Agriculture, Industrial & Energy, Research & Development), End User, Delivery Method - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924674
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The CRISPR gene editing market continues to accelerate as advancements in molecular engineering drive adoption across industries. Senior leaders across life sciences, agriculture, and biotechnology are focusing on precise genome modification to enable innovation, improve efficiency, and gain strategic advantages in dynamic environments.

Market Snapshot: CRISPR Gene Editing Market Growth

The CRISPR gene editing market grew from USD 3.77 billion in 2024 to USD 4.43 billion in 2025. It is projected to expand at a CAGR of 16.96%, reaching USD 9.67 billion by 2030. This robust trajectory reflects growing demand for advanced genomic tools in research, therapeutics, agriculture, and industrial applications. Market expansion is supported by continuous investment, regulatory advancements, and wider acceptance of gene editing solutions.

Scope & Segmentation

This research provides strategic segmentation and extensive coverage of the CRISPR gene editing landscape for informed decision-making across the following dimensions:

  • Editing Techniques: Base Editing, Cas9, Cpf1, Prime Editing, Talen, Zfn
  • Applications: Agriculture (crop improvement and livestock), Industrial & Energy (bio-based chemicals, biofuels), Research & Development (basic research, drug discovery), Therapeutic (ex vivo and in vivo therapies covering hematopoietic stem cell, T cell, oncology, and rare genetic disorders)
  • End Users: Academic & research institutes (public research, universities), Agricultural companies (animal health, crop providers), Contract research organizations (clinical and preclinical services), Pharma & biotech companies (large pharma, small and medium biotech)
  • Delivery Methods: Non-viral methods (electroporation, lipid nanoparticles, physical methods), Vectors (plasmid and viral vectors)
  • Geographies: Americas (United States by key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major and emerging markets), Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and others)
  • Leading Companies: Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Agilent Technologies, Qiagen N.V., New England Biolabs, Illumina, GenScript Biotech, Synthego, Takara Bio Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Refinement of editing techniques such as base and prime editing is broadening the scope of actionable targets, benefitting research innovations and expanding therapeutic options.
  • Collaborations between leading biotech and pharmaceutical companies are driving the commercialization of gene editing solutions, particularly in cell therapies and agricultural trait development.
  • Regional policy distinctions and evolving regulatory frameworks influence the speed of adoption, with North America, Europe, and Asia-Pacific presenting unique opportunities and barriers.
  • Contract research organizations play a vital role in bridging R&D and validation for both established firms and startups, accelerating time to market.
  • Segment demand is strongly shaped by end-user needs, with academic institutions championing initial discoveries while industry partners scale and translate these findings into viable products.

Tariff Impact: United States Tariffs and Supply Chain Adjustments

Recent United States-imposed tariffs on gene editing reagents and equipment are altering global supply chains. Reaction strategies include re-shoring production, modifying supply routes, and greater in-house manufacturing of critical components. These adjustments drive organizations to reassess collaboration terms and diversify their reagent portfolios, facilitating supply chain stability and building industry resilience over the long term.

Methodology & Data Sources

The report employs a robust research process including expert interviews, regulatory reviews, and validation through industry panels. Primary and secondary data were synthesized and rigorously cross-verified. Segmentation covers technology, application, end user, and delivery method for comprehensive market intelligence.

Why This Report Matters

  • Receive actionable recommendations to optimize regulatory navigation, partnership strategy, and technology investments in the CRISPR gene editing market.
  • Gain a structured overview of emerging business models, risk mitigation in procurement, and credible market forecasts tailored for senior decision-making.

Conclusion

As the CRISPR gene editing market evolves, leaders must adapt to both technological and regulatory shifts. This report offers the clarity and strategic depth needed to guide organizational success within a complex and competitive ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in high-fidelity Cas9 variants reducing off-target effects in therapeutic applications
5.2. Breakthroughs in prime editing platforms enabling multi-base corrections for genetic diseases
5.3. Development of nonviral delivery vectors for tissue-specific CRISPR therapeutics in vivo
5.4. AI-driven CRISPR guide RNA design tools enhancing specificity and minimizing unintended edits
5.5. Commercial scaling of cGMP manufacturing for CRISPR reagents to support clinical trial demand
5.6. Regulatory alignment initiatives streamlining global approval processes for CRISPR therapies
5.7. Integration of base editing technologies targeting single-nucleotide disorders in clinical pipelines
5.8. Emerging CRISPR diagnostics for rapid point-of-care pathogen detection and genetic screening
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. CRISPR Gene Editing Market, by Type
8.1. Introduction
8.2. Base Editing
8.3. Cas9
8.4. Cpf1
8.5. Prime Editing
8.6. Talen
8.7. Zfn
9. CRISPR Gene Editing Market, by Application
9.1. Introduction
9.2. Agriculture
9.2.1. Crop Improvement
9.2.2. Livestock
9.3. Industrial & Energy
9.3.1. Bio-based Chemicals
9.3.2. Biofuels
9.4. Research & Development
9.4.1. Basic Research
9.4.2. Drug Discovery
9.5. Therapeutic
9.5.1. Ex Vivo Therapy
9.5.1.1. Hematopoietic Stem Cell Therapy
9.5.1.2. T Cell Therapy
9.5.2. In Vivo Therapy
9.5.2.1. Oncology
9.5.2.2. Rare Genetic Disorders
10. CRISPR Gene Editing Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Public Research Institutes
10.2.2. Universities
10.3. Agricultural Companies
10.3.1. Animal Health Companies
10.3.2. Crop Providers
10.4. Contract Research Organizations
10.4.1. Clinical Services
10.4.2. Preclinical Services
10.5. Pharma & Biotech Companies
10.5.1. Large Pharma
10.5.2. Small & Medium Biotech
11. CRISPR Gene Editing Market, by Delivery Method
11.1. Introduction
11.2. Non-Viral Methods
11.2.1. Electroporation
11.2.2. Lipid Nanoparticles
11.2.3. Physical Methods
11.3. Vectors
11.3.1. Plasmid Vectors
11.3.2. Viral Vectors
12. Americas CRISPR Gene Editing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa CRISPR Gene Editing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific CRISPR Gene Editing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Danaher Corporation
15.3.4. Agilent Technologies, Inc.
15.3.5. Qiagen N.V.
15.3.6. New England Biolabs, Inc.
15.3.7. Illumina, Inc.
15.3.8. GenScript Biotech Corporation
15.3.9. Synthego, Inc.
15.3.10. Takara Bio Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CRISPR GENE EDITING MARKET: RESEARCHAI
FIGURE 24. CRISPR GENE EDITING MARKET: RESEARCHSTATISTICS
FIGURE 25. CRISPR GENE EDITING MARKET: RESEARCHCONTACTS
FIGURE 26. CRISPR GENE EDITING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BASE EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CAS9, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CAS9, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CPF1, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CPF1, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PRIME EDITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PRIME EDITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TALEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ZFN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BIO-BASED CHEMICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BIO-BASED CHEMICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BIOFUELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY T CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY T CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PUBLIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL HEALTH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL HEALTH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CROP PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CROP PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SMALL & MEDIUM BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SMALL & MEDIUM BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 191. CANADA CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 193. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. CANADA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 196. CANADA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 197. CANADA CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 198. CANADA CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 199. CANADA CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 200. CANADA CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 201. CANADA CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 202. CANADA CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 203. CANADA CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 204. CANADA CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 205. CANADA CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 206. CANADA CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 207. CANADA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. CANADA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. CANADA CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 210. CANADA CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 211. CANADA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 212. CANADA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 213. CANADA CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 214. CANADA CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 215. CANADA CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 216. CANADA CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 217. CANADA CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 218. CANADA CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 219. CANADA CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 220. CANADA CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 221. CANADA CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2018-2024 (USD MILLION)
TABLE 222. CANADA CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2025-2030 (USD MILLION)
TABLE 223. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. MEXICO CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 228. MEXICO CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 229. MEXICO CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 230. MEXICO CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 231. MEXICO CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 232. MEXICO CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 233. MEXICO CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 234. MEXICO CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 235. MEXICO CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 236. MEXICO CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 237. MEXICO CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 238. MEXICO CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 239. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. MEXICO CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 242. MEXICO CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 243. MEXICO CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 244. MEXICO CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 245. MEXICO CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 246. MEXICO CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 247. MEXICO CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 248. MEXICO CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 249. MEXICO CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 250. MEXICO CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 251. MEXICO CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY EX VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY IN VIVO THERAPY, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY VECTORS, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY AGRICULTURE, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY INDUSTRIAL & ENERGY, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2030 (U

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this CRISPR Gene Editing market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • New England Biolabs, Inc.
  • Illumina, Inc.
  • GenScript Biotech Corporation
  • Synthego, Inc.
  • Takara Bio Inc.

Table Information